Le Lézard
Classified in: Health
Subjects: CCA, PET, FVT

IDEXX Laboratories to Release 2017 Third Quarter Financial Results



WESTBROOK, Maine, Oct. 5, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2017 third quarter financial results for Tuesday, October 31, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-230-1092 or 1-612-288-0340 and reference confirmation code 431383. Replay of the conference call will be available through Tuesday, November 7, 2017 by dialing 1-800-475-6701 or 1-320-365-3844 and referencing replay code 431383.

IDEXX Laboratories, Inc. logo. (PRNewsFoto/IDEXX Laboratories, Inc.)

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of the S&P 500® index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Contact:
Investor Relations:
Kerry Bennett   
207-556-8155

SOURCE IDEXX Laboratories, Inc.


These press releases may also interest you

at 14:03
Abattis Bioceuticals Corp. (the "Company" or "Abattis") is pleased to announce that CannaNUMUS Blockchain Inc. ("CannaNUMUS"), a company in which Abattis has a 49% ownership interest, has entered into an agreement to acquire (the "Investment") a...

at 14:00
EnterBridge Technologies Inc., a Richmond-based technology firm, today announced the acquisition of Richmond-based health data analytics firm, SMA Informatics Partners LLC, and its subsidiaries to form a new entity, New Health Analytics LLC (NHA)....

at 14:00
In the picturesque Shenandoah Valley, a vibrant community of nearly 200 independent senior residents, medical and continuing care providers, and their Lexington, Virginia neighbors gathered Thursday for a highly celebrated groundbreaking ceremony...

at 14:00
The Board of Directors of Huntsman Cancer Foundation has elected Peter R. Huntsman as Chairman of the Board effective immediately. He replaces his father, Jon M. Huntsman, Sr., who founded Huntsman Cancer Institute (HCI) and was its principal...

at 13:58
Research funded by The ALS Association's Lawrence and Isabel Barnett Drug Development Program recently uncovered a new way to slow muscle paralysis in mice with ALS, findings that could point to new approaches to therapy for people with ALS....

at 13:50
In the news release, HealthCombix, a Leading Blockchain Healthcare Platform, Partners with Y Combinator Alumnus NuCypher, issued 18-Feb-2018 by HealthCombix over PR Newswire, we are advised by the company that the partnership was announced two days...




News published on 5 october 2017 at 14:00 and distributed by: